STATE STREET CORP - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 68 filers reported holding SOLENO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$43,000
-17.3%
231,7410.0%0.00%
Q1 2022$52,000
-42.2%
231,741
+5.3%
0.00%
Q4 2021$90,000
-55.7%
220,1000.0%0.00%
Q3 2021$203,000
-19.1%
220,1000.0%0.00%
Q2 2021$251,000
-76.5%
220,100
-74.0%
0.00%
Q1 2021$1,066,000
-23.4%
846,387
+17.3%
0.00%
Q4 2020$1,392,000
+44.0%
721,387
+87.2%
0.00%
Q3 2020$967,000
+45.9%
385,331
+28.9%
0.00%
Q2 2020$663,000298,8600.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders